OTCMKTS:TRUMY Terumo (TRUMY) Stock Price, News & Analysis $14.99 0.00 (0.00%) As of 05/22/2026 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock About Terumo Stock (OTCMKTS:TRUMY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Terumo alerts:Sign Up Key Stats Today's Range$14.95▼$15.0350-Day Range$12.15▼$14.9952-Week Range$12.08▼$19.64Volume54,480 shsAverage Volume294,197 shsMarket Capitalization$22.11 billionP/E Ratio24.57Dividend Yield0.87%Price TargetN/AConsensus RatingHold Company Overview Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings. Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags. Through its Terumo BCT subsidiary, the company also provides apheresis, blood component management and cell therapy technologies used by blood banks, transfusion services and cell-therapy developers. Terumo’s portfolio emphasizes single-use medical devices and clinically oriented systems designed to improve procedural outcomes and patient safety. Founded in the early 20th century and headquartered in Tokyo, Terumo has grown into a multinational supplier with operations and sales networks across Asia, the Americas and Europe. The company distributes products globally through a combination of regional subsidiaries, direct sales teams and distribution partners, serving hospitals, specialty clinics and blood centers. As a publicly listed Japanese corporation, Terumo also maintains an American depositary receipt (ADR) listing that enables trading on overseas markets.AI Generated. May Contain Errors. Read More Receive TRUMY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Terumo and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRUMY Stock News HeadlinesTerumo ADR Stock Price HistoryMay 17, 2026 | investing.comTerumo Corporation (TRUMY) Q4 2026 Earnings Call TranscriptMay 17, 2026 | seekingalpha.comRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift. | Porter & Company (Ad)Terumo (OTCMKTS:TRUMY) Trading 5.1% Higher - Here's What HappenedMay 17, 2026 | americanbankingnews.comReviewing Else Nutrn (OTCMKTS:BABYF) and Terumo (OTCMKTS:TRUMY)May 15, 2026 | americanbankingnews.comTerumo Corporation (TRUMY) Q3 2026 Earnings Call TranscriptFebruary 13, 2026 | seekingalpha.comTerumo Corporation (TRUMY) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 13, 2026 | seekingalpha.comTerumo Corporation (TRUMY) Q2 2026 Earnings Call TranscriptNovember 12, 2025 | seekingalpha.comSee More Headlines TRUMY Stock Analysis - Frequently Asked Questions How have TRUMY shares performed this year? Terumo's stock was trading at $14.49 on January 1st, 2026. Since then, TRUMY stock has increased by 3.5% and is now trading at $14.99. How were Terumo's earnings last quarter? Terumo Corp. (OTCMKTS:TRUMY) released its quarterly earnings results on Friday, May, 15th. The company reported $0.11 earnings per share for the quarter, hitting analysts' consensus estimates of $0.11. The business had revenue of $1.90 billion for the quarter, compared to analysts' expectations of $1.84 billion. Terumo had a net margin of 12.09% and a trailing twelve-month return on equity of 9.35%. When did Terumo's stock split? Shares of Terumo split on Thursday, March 28th 2024.The 2-1 split was announced on Thursday, March 28th 2024. The newly issued shares were distributed to shareholders after the closing bell on Thursday, March 28th 2024. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. How do I buy shares of Terumo? Shares of TRUMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/15/2026Today5/26/2026Next Earnings (Estimated)8/06/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryPersonal Services Current SymbolOTCMKTS:TRUMY Previous SymbolNASDAQ:TRUMY CIK1446672 Webwww.terumo.co.jp Phone(133) 374-8111Fax813-3374-8399Employees30,000Year Founded1964Profitability EPS (Trailing Twelve Months)$0.61 Trailing P/E Ratio24.57 Forward P/E Ratio23.79 P/E GrowthN/ANet Income$902.88 million Net Margins12.09% Pretax MarginN/A Return on Equity9.35% Return on Assets6.81% Debt Debt-to-Equity Ratio0.07 Current Ratio1.51 Quick Ratio0.89 Sales & Book Value Annual Sales$7.52 billion Price / Sales2.94 Cash Flow$0.90 per share Price / Cash Flow16.66 Book Value$6.10 per share Price / Book2.46Miscellaneous Outstanding Shares1,475,070,000Free FloatN/AMarket Cap$22.11 billion OptionableNot Optionable Beta0.62 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:TRUMY) was last updated on 5/26/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredThe S-1 just dropped. 22 days left.The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...Behind the Markets | SponsoredMy crisis of conscienceEmmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...Porter & Company | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredYour book attachedBill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...Profits Run | SponsoredTrump Admin to Pump $1 Billion into this “Off-the-Radar” AI StockThe U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...InvestorPlace | SponsoredOpportunity Forming in a U.S. Supply-Chain Weak Spot?America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terumo Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terumo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
